000150861 000__ 01524fam\a2200349\a\4500
000150861 001__ 150861
000150861 005__ 20220217103308.0
000150861 008__ 920930s1992\\\\dcua\\\\\\\\\f000\0\eng\d
000150861 020__ $$a0160391024
000150861 035__ $$a(OCoLC)ocm26700832
000150861 035__ $$9(IS)TVS8837
000150861 035__ $$9AAR6988SI
000150861 035__ $$a150861
000150861 040__ $$aFTC$$cFTC$$dGPO
000150861 043__ $$an-us---
000150861 049__ $$aISUW
000150861 074__ $$a1019-A
000150861 0860_ $$aY 4.En 2/3:102-132
000150861 088__ $$aSerial no. 102-132 (United States. Congress. House. Committee on Energy and Commerce)
000150861 090__ $$aRC924.5.S34$$bU5H 1992
000150861 1101_ $$aUnited States.$$bCongress.$$bHouse.$$bCommittee on Energy and Commerce.$$bSubcommittee on Oversight and Investigations.
000150861 24510 $$aFDA's drug and device review process :$$bhearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Second Congress, second session, February 6, 1992.
000150861 260__ $$aWashington :$$bU.S. G.P.O. :$$bFor sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office,$$c1992.
000150861 300__ $$aiii, 178 p. :$$bill. ;$$c24 cm.
000150861 500__ $$aDistributed to some depository libraries in microfiche.
000150861 500__ $$aShipping list no.: 92-0573-P.
000150861 500__ $$a"Serial no. 102-132."
000150861 61010 $$aUnited States.$$bFood and Drug Administration.
000150861 650_0 $$aSystemic scleroderma.
000150861 650_0 $$aMedical instruments and apparatus$$xSafety regulations$$zUnited States.
000150861 650_0 $$aDrugs$$xTesting$$xLaw and legislation$$zUnited States.
000150861 85230 $$bdfich$$hY 4.EN 2/3:$$i102-132
000150861 909CO $$ooai:library.usi.edu:150861$$pGLOBAL_SET
000150861 948__ $$ac:ajk
000150861 980__ $$aBIB
000150861 980__ $$aGOV RESOURCE